InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,709.54
(
0.01%
)
US TECH 100
19,238.40
(
-0.21%
)
Dow Jones
42,196.52
(
0.09%
)
Brent Oil
75.43
(
1.09%
)
Bitcoin
61,011.10
(
0.64%
)
Post# of 821321
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

SpecTrader

Send PM Follow Ignore
Followers 209
Posts 12050
Boards Moderated 3
Alias Born 08/03/2009

SpecTrader

Re: bossboater post# 107253

Friday, 12/14/2012 9:22:17 AM

Friday, December 14, 2012 9:22:17 AM

Post# of 821321
~AMBS announced that it has licensed the LymPro Alzheimer's Disease Diagnostic Blood Test (LymPro) from Memory Dx, LLC (MDx), formerly known as Provista Life Sciences, Inc....The blood test already received $3,000,000 in grants from the National Institutes of Health (NIH). Huge News IMO
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up